Nerve-Zapping showdown: which procedure best stops a runny nose?

NCT ID NCT07706595

First seen Jul 16, 2026 · Last updated Jul 17, 2026 · Updated 1 time

Summary

This trial compares three FDA-cleared in-office procedures that treat chronic non-allergic rhinitis by targeting the posterior nasal nerve. Radiofrequency ablation (using RhinAer or Neuromark) uses heat, while cryoablation (ClariFix) uses extreme cold to reduce nerve signals that cause runny nose, congestion, and postnasal drip. About 50 adults with chronic rhinitis will be randomly assigned to one of the three treatments and report their symptom changes and quality of life over time.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance
radiofrequency ablation (RhinAer or Neuromark) or cryoablation (ClariFix) of the posterior nasal nerve
What this could lead to
If one method proves superior, it could become the preferred in-office procedure for long-term relief from chronic rhinitis symptoms like runny nose and congestion.
What could go wrong
This is a small, single-center trial (50 participants) comparing already-approved devices, so differences may be subtle or not generalizable. All procedures carry risks of temporary discomfort, bleeding, or incomplete symptom relief.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for CHRONIC RHINITIS are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • Perlman Medical Office at UC San Diego

    La Jolla, California, 92037, United States

  • Veterans Affairs San Diego Healthcare System

    San Diego, California, 92161, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.